Evidence map›Paper›PMID 28648301›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2017

Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.

Barry I Freedman, Kaycee M Sink, Christina E Hugenschmidt, Timothy M Hughes, Jeff D Williamson, Christopher T Whitlow, Nicholette D Palmer, Michael E Miller, Laura C Lovato, Jianzhao Xu and 11 more

Abstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Review
  13. Article
  14. Diabetes, Albuminuria and the Kidney-Brain Axis.Journal of clinical medicine · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

Barry I FreedmanSection on Nephrology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC. Electronic address: bfreedma@wakehealth.edu.
Kaycee M SinkSection on Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Christina E HugenschmidtSection on Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Timothy M HughesSection on Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Jeff D WilliamsonSection on Gerontology and Geriatric Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Christopher T WhitlowDepartment of Radiology, Wake Forest School of Medicine, Winston-Salem, NC.
Nicholette D PalmerDepartment of Biochemistry and Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC.
Michael E MillerDivision of Public Health Sciences, Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
Laura C LovatoDivision of Public Health Sciences, Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
Jianzhao XuDepartment of Biochemistry and Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC.
S Carrie SmithDepartment of Biochemistry and Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC.
Lenore J LaunerNational Institute on Aging, Laboratory of Epidemiology, Demography, and Biometry, National Institutes of Health, Bethesda, MD.
Joshua I BarzilayKaiser Permanente, Atlanta, GA.
Robert M CohenDivision of Endocrinology, Department of Internal Medicine, University of Cincinnati, Veterans Administration Medical Center, Cincinnati, OH.
Mark D SullivanDepartment of Psychiatry, University of Washington, Seattle, WA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA.
R Nick BryanDepartment of Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA.
Benjamin C WagnerAdvanced Neuroscience Imaging Research (ANSIR) Laboratory, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX.
Donald W BowdenDepartment of Biochemistry and Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC.
Joseph A MaldjianAdvanced Neuroscience Imaging Research (ANSIR) Laboratory, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX.
Jasmin DiversDivision of Public Health Sciences, Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
AA-DHS MIND and ACCORD MIND Investigators
Wake Forest University · USAdvanced Imaging Research (United States) · USKaiser Permanente · USNational Institute on Aging · USThe University of Texas Southwestern Medical Center · USUniversity of Cincinnati · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

Subclinical CVD in African American Type 2 DiabeticsR01DK071891 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2007 to 2016
$4.5M
Cerebrovascular Disease and Cognitive Performance in African AmericansR01NS075107 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DIVERS, JASMIN, FREEDMAN, BARRY IRA · 2011 to 2015
$2.8M
Diabetes and the brainZIAAG007420 · NIA · NATIONAL INSTITUTE ON AGING · PI LAUNER, LENORE J · 2009 to 2021
$2.1M
Genetic Determinants of Renal Transplant Survival from African American DonorsR01MD009055 · NIMHD · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DIVERS, JASMIN · 2014 to 2018
$2.0M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095183 · HC · MINNEAPOLIS MEDICAL RESEARCH FDN, INC. · PI GRIMM, RICHARD H · 1999 to 2000
$1.9M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095181 · HC · CASE WESTERN RESERVE UNIVERSITY · PI THIBONNIER, MARC · 1999 to 2000
$1.8M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095184 · HC · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BIGGER, J T · 1999 to 2000
$1.7M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095182 · HC · WAKE FOREST UNIVERSITY · PI GOFF, DAVID C · 1999 to 2000
$1.6M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUS-N01HC95178N01HC095178 · HC · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BYINGTON, ROBERT · 1999 to 2006
$1.5M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETER MELLLITN01HC095180 · HC · UNIVERSITY OF WASHINGTON · PI PROBSTFIELD, JEFFREY · 1999 to 2000
$1.5M
S-nitrosothiol analyzer for the clinical diagnosis of cardiovascular disease markR44HL095181 · NHLBI · ACCORD BIOMATERIALS, INC. · PI PISANO, MICHAEL R · 2010 to 2011
$1.4M
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITUN01HC095179 · HC · MCMASTER UNIVERSITY · PI GERSTEIN, HERTZEL C · 1999 to 2000
$1.3M
NHLBI NIH HHS N01 HC095178NHLBI NIH HHS N01 HC095179NHLBI NIH HHS N01 HC095180NHLBI NIH HHS N01 HC095181NHLBI NIH HHS N01 HC095182NHLBI NIH HHS N01 HC095183NHLBI NIH HHS N01 HC095184NIA NIH HHS K01 AG043547NIDDK NIH HHS F32 DK083214NIDDK NIH HHS R01 DK071891NIMHD NIH HHS R01 MD009055NINDS NIH HHS R01 NS075107
6 · The paper itself

Abstract

backgroundRelationships between early kidney disease, neurocognitive function, and brain anatomy are poorly defined in African Americans with type 2 diabetes mellitus (T2DM). STUDY

designCross-sectional associations were assessed between cerebral anatomy and cognitive performance with estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (UACR) in African Americans with T2DM. SETTING &

participantsAfrican Americans with cognitive testing and cerebral magnetic resonance imaging (MRI) in the African American-Diabetes Heart Study Memory in Diabetes (AA-DHS MIND; n=512; 480 with MRI) and Action to Control Cardiovascular Risk in Diabetes (ACCORD) MIND (n=484; 104 with MRI) studies. PREDICTORS: eGFR (CKD-EPI creatinine equation), spot UACR. MEASUREMENTS: MRI-based cerebral white matter volume (WMV), gray matter volume (GMV), and white matter lesion volume; cognitive performance (Mini-Mental State Examination, Digit Symbol Coding, Stroop Test, and Rey Auditory Verbal Learning Test). Multivariable models adjusted for age, sex, body mass index, scanner, intracranial volume, education, diabetes duration, hemoglobin A

resultsMean participant age was 60.1±7.9 (SD) years; diabetes duration, 12.1±7.7 years; hemoglobin A LIMITATIONS: Cross-sectional; single UACR measurement.

conclusionsIn African Americans with T2DM, mildly high UACR and mildly low eGFR were associated with smaller GMV and increased white matter lesion volume. UACR was associated with poorer processing speed and working memory.

Indexed as

CognitionAgedAlbuminuriaBlack or African AmericanBrainCardiovascular DiseasesCholesterol, LDLCognitive DysfunctionCreatinineCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGlomerular Filtration RateGlycated HemoglobinGray MatterHumansCholesterol, LDLCreatinineGlycated Hemoglobinhemoglobin A1c protein, humanAfrican Americanalbuminuriabrainchronic kidney disease (CKD)cognitive performanceestimated glomerular filtration rate (eGFR)magnetic resonance imaging (MRI)neurocognitive functiontype 2 diabetes mellitus (T2DM)urine albumin-creatinine ratio (UACR)

Identifiers

PMID28648301
PMCPMC5651190
OpenAlexW2636248301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.